膜杰作
Star Staining
描述（Description）
The Human GLP-2R (Luc) HEK293 Reporter Cell was engineered to not only express CREB signaling response element, but also express the receptor full length human GLP-2R (Gene ID:9340), which can drive luciferase expressing systems by GLP-2R agonists or glucagon-like peptide 2 (GLP-2) stimulation. In the absence of agonist or GLP-2, the GLP-2R receptor is not activated and luminescence signal is low. In the presence of agonist or GLP-2, the GLP-2R pathway-activated luminescence can be detected in a dose-dependent manner.
应用说明（Application）
• Screen for agonists that can bind and activate GLP-2R.
生长特性（Growth Properties）
Adherent
筛选标记（Selection Marker）
Puromycin (2 μg/mL) + Hygromycin (20 μg/mL)
培养基（Culture Medium）
DMEM + 10% FBS
冻存液（Freeze Medium）
Serum-free cell cryopreservation medium
装量（Quantity）
1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium
存储（Storage）
Frozen in liquid nitrogen.
支原体检测（Mycoplasma Testing）
Negative
无菌检测（Sterility Testing）
Negative
使用说明（Instructions for Use）
See data sheet for detailed culturing and assay protocol.
Receptor Assay
Expression analysis of human GLP-2R on Human GLP-2R (Luc) HEK293 Reporter Cell by FACS.
Cell surface staining was performed on Human GLP-2R (Luc) HEK293 Reporter Cell or negative control cell using anti-human GLP-2R antibody followed by staining with FITC anti-human IgG antibody.
Protocol
Application
Bioactivity analysis of human GLP-2R agonist (RLU).
This reporter cell was incubated with serial dilutions of human GLP-2R agonist. The EC50 of human GLP-2R agonist (Glepaglutide) was approximately 0.1281 nM.
Protocol
Bioactivity analysis of human GLP-2R agonist (FOLD).
This reporter cell was incubated with serial dilutions of human GLP-2R agonist. The max induction fold of human GLP-2R agonist (Glepaglutide) was approximately 43.99.
Protocol
如有相关细胞池需求请联系我们
背景（Background）
This gene encodes a G protein-coupled receptor that is closely related to the glucagon receptor and binds to glucagon-like peptide-2 (GLP2). Signalling through GLP2 stimulates intestinal growth and increases villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. [provided by RefSeq, Dec 2014]
License Disclosure
This cell line is provided for research use only. This license does not permit you to share, distribute, sell, sublicense, or otherwise make this cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. The license does not permit modification of this cell line in any way. Inappropriate use or distribution of this cell line will result in revocation of the license. Modifications of this cell line, transfer to another facility, or commercial use of the cell lines may require a separate license and additional fees. AcroBiosystems does not warrant the suitability of this cell line for any particular use, and does not accept any liability in connection with the handling or use of this cell line.
